Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00277_DB00744> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00277_DB00744 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00277_DB00744 label "DDI between Theophylline and Zileuton - Zileuton may increase the therapeutic and adverse effects of theophylline by increasing its serum concentration. Monitor for changes in the therapeutic and adverse effects of theophylline if zileuton is initiated, discontinued or dose changed. Dose alterations should be considered. [drugbank_resource:DB00277_DB00744]" assertion.
- drugbank_resource:DB00277_DB00744 identifier "drugbank_resource:DB00277_DB00744" assertion.
- drugbank_resource:DB00277_DB00744 title "DDI between Theophylline and Zileuton - Zileuton may increase the therapeutic and adverse effects of theophylline by increasing its serum concentration. Monitor for changes in the therapeutic and adverse effects of theophylline if zileuton is initiated, discontinued or dose changed. Dose alterations should be considered." assertion.